Harleysville, PA, United States of America

Paul J Coleman

USPTO Granted Patents = 51 

 

 

Average Co-Inventor Count = 3.9

ph-index = 16

Forward Citations = 506(Granted Patents)


Inventors with similar research interests:


Location History:

  • Wallingford, PA (US) (1999 - 2014)
  • Harleysville, PA (US) (2011 - 2018)

Company Filing History:


Years Active: 1999-2018

Loading Chart...
Loading Chart...
Loading Chart...
51 patents (USPTO):

Title: **Innovative Contributions of Paul J Coleman in HIV Research**

Introduction

Paul J Coleman, based in Harleysville, PA, is a distinguished inventor with an impressive portfolio of 51 patents. His work primarily focuses on developing innovative compounds aimed at combating HIV, significantly contributing to the fields of pharmaceutical sciences and infectious disease treatment.

Latest Patents

Among his notable recent patents is the invention titled "Fused Tricyclic Heterocyclic Compounds as HIV Integrase Inhibitors." This invention relates to various derivatives of Fused Tricyclic Heterocycles and their pharmaceutically acceptable salts, providing a new avenue for treating or preventing HIV infection. Another critical patent is for "Substituted Quinolizine Derivatives Useful as HIV Integrase Inhibitors," which describes compounds designed to inhibit HIV integrase, offering potential therapeutic options against HIV infections as well.

Career Highlights

Paul J Coleman has notably worked with esteemed organizations such as Merck Sharp & Dohme Corporation and Merck & Company, Inc. His extensive career has been marked by significant contributions to pharmaceutical innovations, particularly those addressing viral infections. His expertise in medicinal chemistry and drug design has led to breakthrough inventions that help alleviate one of the world's most pressing health issues.

Collaborations

Throughout his career, Coleman has collaborated with talented professionals like Christopher D Cox and John D Schreier. These collaborations have led to the development of promising therapeutic solutions and have expanded the potential applications of his inventions in the field of HIV research.

Conclusion

Paul J Coleman represents a pivotal figure in the ongoing fight against HIV through his inventive work in pharmaceutical development. His 51 patents, particularly those related to innovative HIV integrase inhibitors, exemplify his commitment to advancing public health and his significant influence in the pharmaceutical industry. As the landscape of HIV treatment evolves, Coleman’s contributions will likely remain instrumental in shaping effective therapies for millions worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…